Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-13-Speech-3-611-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-06-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Defective silicone gel breast implants made by French company PIP (debate)2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20120613.33.3-611-000"2
lpv:hasSubsequent	lp_eu:2012-06-13-Speech-3-612-0002
lpv:speaker	lp:Marisa Matias2
lpv:spokenAs	member; ITRE (2012-01-19--2014-06-30)3,3 substitute; Delegation for relations with South Africa (2009-09-16--2014-06-30)3,3 member_of_the_bureau; EUL/NGL (2012-01-23--2014-06-30)3,3 unknown; Bloco de Esquerda (2009-07-14--2014-06-30)3,3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-09-16--2014-06-30)3,3 vice-chair; Delegation for relations with the Mashreq countries (2009-09-17--2014-06-30)3,3 substitute; ECON (2012-05-10--2014-06-30)3,3
lpv:translated text	"Madam President, Commissioner, it is true that six months have already passed since the Poly Implant Prothèse (PIP) scandal. The most unbelievable thing is that, for 10 years, a private company could have managed to operate in the market and give women from 71 countries silicone implants that should be used for construction and manufacturing mattresses. This affected many hundreds of thousands of women, as has already been mentioned: it is estimated at around 500 000. We are talking about estimates because there were failings, serious failings, with this process. We know that what happened with this company was criminal activity, fraud and a matter for the courts. However, we also know that this is a fraud that should be monitored by the courts and the courts will deal with it. Nevertheless, there has been a failure of the law; a legal vacuum that we should tackle. We are responsible for that area. For 10 years, we did not manage to identify what the criminals managed to identify, so there was a vacuum in terms of monitoring, in terms of traceability, in terms of files, in terms of records; everything failed. However, the people in charge of this company managed to put into practice something that we failed to monitor, so this process does not just concern the issue of the lack of information in this regard and, in fact, all those issues relating to breast implants: those are very important, but there is also the humiliation of thousands of women and the humiliation, in particular, of those women who had to undergo tests to know whether or not they had the correct implants. We are talking about a public health issue and we cannot be lax as regards public health: we monitor so many unnecessary things – we even monitor the authenticity of replacement car parts – and it is still not long since we adopted a directive on this. We have to monitor that which is essential to people’s lives. The revision of the Medical Devices Directive is good news, but it would be better news if we did not have to do it. However, now that we are going to do it, let us put in place transparency, monitoring and penalties with conditions and traceability because, unfortunately, even if penalties are applied, they will not benefit the women who suffered from this problem, so states should accept full liability."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph